July 18, 2008 |
Eric Horne |
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.
M. Uchigashima….M. Watanabe. J Neurosci 27:3663-3676, 2007.
|
June 20, 2008 |
Aaron Miller |
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain.
P.C. Staton….I.P. Chessell. Pain May 23, 2008 (Epub ahead of print).
|
June 6, 2008 |
Faith Reyes |
Endocannabinoids mediate neuron-astrocyte communication.
M. Navarrete & A. Araque. Neuron 57:883-893, 2008.
|
May 23, 2008 |
Eiron Cudaback |
Network that triggers neurite outgrowth design logic of a cannabinoid receptor signaling.
K.D. Bromberg….R. Iyengar. Science 320:903-909, 2008.
|
May 9, 2008 |
Nephi Stella |
Activation of the endocannabinoid system by organophosphorus nerve agents.
D.K. Nomura….J.E. Casida. Nat Chem Biol, April 27, 2008 (Epub ahead of print).
|
April 11, 2008 |
Yi Hsing Lin |
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3.
R. Rozenfeld & L.A. Devi. FASEB J. Published online March 7, 2008.
|
March 28, 2008 |
Will Marrs |
Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids.
R. Cachope….A.E. Pereda. Neuron 56:1034-1047, 2007.
|
February 29, 2008 |
Elsa Raibon |
Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.
P. Zhao….M.E. Abood. Eur J Neurosci 27:572-579, 2008.
|
December 21, 2007 |
Aaron Miller |
Hemopressin is an inverse agonist of CB1 cannabinoid receptors.
A.S. Heimann….L.A. Devi. PNAS 104:20588–20593, 2007.
|
December 7, 2007 |
Faith Reyes |
Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.
F.R. Bambico....G. Gobbi. J Neurosci 27:11700–11711, 2007.
|
October 26, 2007 |
Ethan Russo |
History of cannabis and its preparations in saga, science, and sobriquet.
E.B. Russo. Chem Biodiversity 4:1614-1648, 2007.
|
October 12, 2007 |
Eiron Cudaback |
Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.
S. Dirikoc....J. Chabry. J. Neurosci 27:9537-9544, 2007.
|
September 14, 2007 |
Nephi Stella |
Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington’s disease
.
T. Bisogno....V. Di Marzo. Neurochem Int, in press.
Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington’s disease mutation in peripheral lymphocytes.
N. Battista....M. Maccarrone. Neurobiol Dis 27:108–116, 2007.
|
August 17, 2007 |
Michelle Sexton |
Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and –independent immunomodulatory effects.
S. Raduner….J. Gertsch. JBC 281:14192-14206, 2006.
|
July 24, 2007 |
Aaron Miller |
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.
N. Agarwal....R. Kuner. Nature Neurosci 10:870-879, 2007.
|
July 17, 2007 |
Faith Reyes |
Neuronal connectivity hardwiring the brain: endocannabinoids shape neuronal connectivity.
P. Berghuis….T. Harkany. Science 316:1212-1216, 2007.
|
July 3, 2007 |
Eiron Cudaback |
Attenuation of allergic contact dermatitis through the endocannabinoid system.
M. Karsak….A. Zimmer. Science 316:1494-1497, 2007.
|
May 22, 2007 |
Nephi Stella |
Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation.
M. Bouaboula….P. Casellas. Mol Pharmacol 55:473–480, 1999.
|
May 8, 2007 |
Tanya Daigle |
A molecular basis of analgesic tolerance to cannabinoids.
A. Tappe-Theodor….R. Kuner. J Neurosci 27:4165–4177, 2007.
|
April 24, 2007 |
Aaron Miller |
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.
K. Maresz….B.N. Dittel. Nat Med 13:492-497, 2007.
|
April 10, 2007 |
Faith Reyes |
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
J.E. Lauckner…K. Mackie. PNAS 102:19144-19149, 2005.
|
March 27, 2007 |
Eiron Cudaback |
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.
S. Batkai....P. Pacher. FASEB J, March 7, 2007 (Epub ahead of print).
|
March 13, 2007 |
Nephi Stella |
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
J.L. Shoemaker….P.L. Prather. J Neurochem, January 4, 2007 (Epub ahead of print).
|
February 27, 2007 |
Will Marrs |
Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus.
Y. Hashimotodani.…M. Kano. J Neurosci 27(5):1211–1219, 2007.
|
January 24, 2007 |
Tanya Daigle |
The role of protein synthesis in striatal long-term depression.
H.H. Yin….D.M. Lovinger. J Neurosci 26(46):11811–11820, 2006.
|
December 19, 2006 |
Aaron Miller |
Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats.
R. Mathison….K. A.Sharkey. Br J Pharmacol 142:1247–1254, 2004.
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.
C. Rousseaux….P. Desreumaux. Nature Med, December 10, 2006 (Epub ahead of print).
|
December 5, 2006 |
Faith Reyes |
Serotonin 5-HT receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism.
J.C. Parrish….D.E. Nichols. J Neurochem 99(4):1164-1175, 2006.
|
October 31, 2006 |
Tanya, Faith, Aaron |
Review of Society for Neuroscience 2006 Meeting.
|
October 10, 2006 |
Brady Atwood |
Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum. real-time visualization with confocal fluorescence resonance energy transfer.
K. Herrick-Davis….J.E. Mazurkiewicz. J Biol Chem 281:27109-27116, 2006.
|
September 26, 2006 |
Nephi Stella |
A biosynthetic pathway for anandamide.
J. Liu….G. Kunos. PNAS 103:13345-13350, 2006.
|
September 12, 2006 |
Eiron Cudaback |
Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of bad to mitochondria.
W. Jia….P.S. Nagarkatti. Mol Cancer Res 4:549-562, 2006.
|
August 29, 2006 |
Chris Kearn |
Induction of KROX-24 by endogenous CB1 receptors in neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the PI3K pathway.
E.S. Graham….M. Glass. JBC Papers, July 24, 2006 (Epub ahead of print).
|
August 15, 2006 |
Giulio Muccioli |
Endocannabinoid biosynthesis proceeding through glycerophospho-n-acyl ethanolamine and a role for alpha/beta hydrolase 4 in this pathway.
G.M. Simon & B.F. Cravatt. JBC papers, July 3, 2006 (Epub ahead of print).
|
July 18, 2006 |
Jane Lauckner |
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadiopocytes.
M. Gary-Bobo….M. Bensaid. Mol Pharmacol 69:471-478, 2006.
|
July 5, 2006 |
Ken, Chris, Nephi |
Report on ICRS Meeting. Meet in BB1444 (Anesthesiology Library).
|
June 6, 2006 |
Ken Mackie |
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
B. Julien….S. Lotersztajn. Gastroenterology 128:742–755, 2005.
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
F. Teixeira-Clerc….S. Lotersztajn. Nat Med, May 21, 2006 (Epub ahead of print).
|
May 9, 2006 |
Alex Straiker |
Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells.
L. Glickfeld & M. Scanziani. Nat Neurosci, April 30, 2006 (Epub ahead of print).
|
April 25, 2006 |
Jane Sullivan |
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
Y. Kawamura….M. Kano. J Neurosci 26:2991-3001, 2006.
|
April 11, 2006 |
Brooke Kelley |
The ryanodine receptor regulates endogenous cannabinoid mobilization in the hippocampus.
M. Isokawa & B.E. Alger. J Neurophysiol, in press (February 8, 2006).
|
March 28, 2006 |
Tanya Daigle |
Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors.
C. Leterrier….Z. Lenkei. J Neurosci 26:3141-3153, 2006.
|
March 14, 2006 |
Aaron Miller |
Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils.
R. Kurihara….H. Yamamura. JBC Papers, in press. Published on March 2, 2006 as Manuscript M510871200.
|
February 28, 2006 |
Faith Reyes |
Cannabinoid receptor type 2 agonists induce transcription of the µ-opioid receptor gene in Jurkat T cells.
C. Börner….J. Kraus. Molecular Pharmacology Fast Forward. Published on January 24, 2006 as doi:10.1124/mol.105.018325.
|
February 14, 2006 |
Nephi Stella |
A second N-acylethanolamine hydrolase in mammalian tissues.
N. Uedaa….D.M. Lambert. Neuropharmacology 48:1079-1085, 2005.
Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
K. Tsuboi….N. Ueda. J Biol Chem 280:11082–11092, 2005.
|
January 31, 2006 |
Eiron Cudaback |
Peripheral cannabinoid receptor, CB2, regulates bone mass.
O. Ofek….I. Bab. PNAS 103: 696–701, 2006.
|
January 17, 2006 |
Chris Kearn |
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.
G. Gobbi….D. Piomelli. PNAS 102:18620–18625, 2005.
|
January 3, 2006 |
Chris Hague |
Allosteric modulation of the cannabinoid CB1 receptor.
M.R. Price….R.A. Ross. Mol Pharmacol 68:1484–1495, 2005.
|
December 6, 2005 |
|
Review of Society for Neuroscience Meeting.
|
October 25, 2005 |
Jane Lauckner |
Quantum dots conjugated to Bombesin or Angiotensin II label the cognate G protein-coupled receptor in living cells.
S.H. Young, E. Rozengurt. Cell Am J Physiol Cell Physiol, October 19, 2005 (Epub ahead of print).
|
October 11, 2005 |
Ken Mackie |
Functional expression of single-chain heterodimeric G-protein-coupled receptors for adenosine and dopamine.
T. Kamiya….H. Nakata. Cell Struct Funct 29:139-145, 2005.
|
September 27, 2005 |
Alex Straiker |
Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids.
J.A. Lopez-Moreno….M. Navarro. J Neurosci 25:7499-7506, 2005.
Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
A.F. Hoffman….C.R. Lupica. Eur J Pharmacology, in press.
|
September 13, 2005 |
Jane Sullivan |
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus.
J.K. Makara….D. Piomelli. Nature Neurosci 8:1139-1141, 2005.
|
August 30, 2005 |
Brooke Kelley |
Δ9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
S.A. Varvel….A.H. Lichtman. J Pharmacol Exp Ther 314:329-337, 2005.
|
August 16, 2005 |
Tanya Daigle |
An endocannabinoid mechanism for stress-induced analgesia.
A. Hohmann….D. Piomelli. Nature 435:1108-1112, 2005.
|
June 21, 2005 |
Christopher Kearn |
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.
A.I. Idris….S.H. Ralston. Nat Med, May 22, 2005 (Epub ahead of print).
|
June 7, 2005 |
Alan Tseng |
Neuromodulation via conditional release of endocannabinoids in the spinal locomotor network.
P. Kettunen….A. El Manira. Neuron 45:95-104, 2005.
|
May 24, 2005 |
Anke Witting |
Endocannabinoid signaling depends on the spatial pattern of synapse activation.
P. Marcaggi & D. Attwell. Nature Neurosci, May 1, 2005 (Epub ahead of print).
|
May 10, 2005 |
Eiron Cudaback |
Identification of WIN55212-3 as a competitive neutral antagonist of the human cannbinoid CB2 receptor.
J. Savinainen….J.T. Laitinen. Br J Pharmacology, April 25, 2005 (Epub ahead of print).
|
April 26, 2005 |
Canceled |
David Greenberg from the Buck Institute will talk about "Cannabinoids, Neuroprotection and Neurogenesis" at 2:30 in T-747.
|
April 12, 2005 |
Nephi Stella |
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.
S. Steffens….F. Mach. Nature 434:782-786, 2005.
|
March 29, 2005 |
Mike Myoga |
Different G protein-coupled receptor kinases govern G protein and Cß-arrestin-mediated signaling of V2 vasopressin receptor.
X.R. Ren….R.J. Lefkowitz. PNAS 1448–1453, 2005.
|
March 15, 2005 |
Jane Lauckner |
Real-time monitoring of receptor and G-protein interactions in living cells.
C. Galés….M. Bouvier.
Nature Methods 2:177-184. 2005.
A FLAsH-based FRET approach to determine G protein-coupled receptor activation in living cells.
C. Hoffmann….M. Lohse.
Nature Methods 2:171-176, 2005.
|
March 1, 2005 |
Ken Mackie |
Synaptic activity augments muscarinic acetylcholine receptor-stimulated Inositol 1,4,5-Trisphosphate production to facilitate Ca2+ release in hippocampal neurons.
M.S. Nash….S.R. Nahorski. J Biol Chem 279:49036-49044, 2004.
|
February 17, 2005 |
Alex Straiker |
Phospholipase Cß serves as a coincidence detector through its Ca(2+) dependency for triggering retrograde endocannabinoid signal.
Y. Hashimotodani….M. Kano. Neuron 45:257-268, 2005.
|
February 3, 2005 |
Jane Sullivan |
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids.
A. Bacci….D.A. Prince. Nature 431:312-316, 2004.
|
January 20, 2005 |
Christopher Kearn |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries.
K.M. Gauthier….W.B. Campbell. American Physiological Society, 2004.
|
January 6, 2005 |
Tanya Daigle |
Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area.
A.C. Riegel & C.R. Lupica. J Neurosci 24:11070-11078, 2004.
|
December 9, 2004 |
Alan Tseng |
Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals.
F. Lallemand….P. De Witte. Alcohol & Alcoholism 39:486-492, 2004.
Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
J.A. Lopez-Moreno….M. Navarro. J Neurosci 24:8245-8252, 2004.
|
November 12, 2004 |
|
Review of Society for Neuroscience Meeting.
|
October 28, 2004 |
|
Review of Society for Neuroscience Meeting.
|
October 14, 2004 |
Nephi Stella |
Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptkake.
S. Ortega-Gutierrez….B.F. Cravatt. Biochemistry 43:8184-8190, 2004.
|
September 2, 2004 |
Anke Witting |
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide.
M. McFarland….E. Barker. JBC Papers, in press. Published on August 3, 2004 as Manuscript M407250200.
|
August 19, 2004 |
Eiron Cudaback |
Functional disassociation of the central and peripheral fatty acid amide signaling systems.
B.F. Cravatt….A.H. Lichtman. PNAS 101:10821-10826, 2004.
|
August 5, 2004 |
Mike Myoga |
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
C.D. Fegley….D. Piomelli. PNAS 101:8756–8761, 2004.
RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol.
T.P. Dinh….D. Piomelli. Mol Pharmacol, July 22, 2004 (Epub ahead of print).
|
July 22, 2004 |
Jane Lauckner |
Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
C. Kushmerick….H. von Gersdorff. J Neurosci 24(26):5955-5965, 2004.
|
July 8, 2004 |
|
Ken, Chris and Alex will give a summary of the new research presented at the ICRS in Naples.
|
June 10, 2004 |
Lisa Walter |
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model.
X. Ni….R.F Tuma. Mult Scler 10:158-164, 2004.
|
May 27, 2004 |
Ken Mackie |
Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
Y. Fukudome….M. Kano. Eur J Neuroscience 19:2682-2692, 2004.
|
May 13, 2004 |
Christopher Kearn |
The peripheral cannabinoid receptor CB2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
M.A. Jorda….R. Delwel. Blood, March 23, 2004 (Epub ahead of print).
|
April 29, 2004 |
Alex Straiker |
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study.
E. Murillo-Rodriguez….P.J. Shiromani. Sleep 26:943-947, 2003.
|
April 15, 2004 |
Tanya Daigle |
Brief synaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids.
S.P. Brown….W.G. Regehr. Nature Neurosci 6:1048-1057, 2003.
|
April 1, 2004 |
Alan Tseng |
Modulation of extracellular signal-regulated kinases cascade by chronic D9-tetrahydrocannabinol treatment.
T. Rubino….D. Parolaro. Mol Cell Neurosci 25:355-362, 2004.
A single in-vivo exposure to D9-tetrahydrocannabinol blocks endocannabinoid-mediated synaptic plasticity.
S. Mato….O.J. Manzoni.
|
March 18, 2004 |
Nephi Stella
|
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus.
M. Maccarrone….A. Finazzi-Agro.
Mol Hum Reprod. Advance Access published February 16, 2004
Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation.
H. Wang….S.K. Dey.
PNAS 100(25):14914-14919, 2003.
|
March 4, 2004 |
Ariela Gordon-Shaag
|
Gi protein activation in intact cells involves subunit rearrangement rather than dissociation.
M. Bunemann….M.J. Lohse.
PNAS 100:16077–16082, 2003.
|
February 18, 2004 |
Anke Witting
|
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1.
S.E. Jordt….D. Julius.
Nature 427:260-265, 2004.
|
February 5, 2004 |
Eiron Cudaback
|
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimmers.
L. Yao....I. Diamond.
PNAS 100:14379-14384, 2003.
|
January 22, 2004 |
Lisa Walter
|
Molecular characterization of a phospholipase D generating anandamide and its congeners.
Y. Okamoto....N. Ueda.
JBC Papers, in press, published on November 21, 2003.
|
January 8, 2004 |
Mike Myoga |
The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro.
Z. Xia....B.L. Roth.
Neurosci 122:907-920,2003.
|
November 26, 2003 |
Ken Mackie
|
Measurement of the millisecond activation switch of G protein-coupled receptors in living cells.
J.P. Vilardaga....M.J. Lohse.
Nature Biotech 21:807-812,2003.
|
October 30, 2003 |
Christopher Kearn
|
A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors.
M. Tanowitz & M. von Zastrow.
JBC Papers, in press. Published on August 25, 2003 as Manuscript M304504200.
|
October 16, 2003 |
Lisa Walter
|
CB1 cannabinoid receptors and on-demand defense against excitotoxicty.
G. Marsicano....B. Lutz.
Science 302:84-88, 2003.
|
October 2, 2003 |
Alex Straiker
|
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
M.J. Wallace....R.J. Delorenzo.
JPET 307:129-137, 2003.
Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures.
K. Chen....I. Soltesz.
Neuron 39:599-611, 2003.
|
August 21, 2003 |
Alan Tseng
|
Membrane assembly of the cannabinoid receptor 1: impact of a long n-terminal tail
.
H. Andersson....C.N. Chin.
Mol Pharmacol 64(3):570-577, 2003.
|
August 7, 2003 |
Nephi Stella
|
Calcium dependence of retrograde inhibition by endocannabinoids at synapses onto purkinje cells.
S.D. Brenowitz & W.G. Regehr.
J Neurosci 23(15):6373-6384, 2003.
|
July 24, 2003 |
Ariela Gordon-Shaag
|
Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
J. Ahluwalia....I. Nagy.
Eur J Neurosci 17:2611-1618, 2003.
|
July 10, 2003 |
Mackie Lab |
Research presented at ICRS Meeting.
|
May 29, 2003 |
Anke Witting |
Heterosynaptic LTD of hippocampal GABAergic synapses. a novel role of endocannabinoids in regulating excitability.
V. Chevaleyre & P.E. Castillo.
Neuron 38(3):461-72, 2003.
Excitement reduces inhibition via endocannabinoids.
T.F. Freund & N. Hajos.
Neuron 38(3):362-365, 2003.
|
May 15, 2003 |
Eiron Cudaback |
Therapeutic action of cannabinoids in a murine model of multiple sclerosis.
A. Arevalo-Martin....C. Guaza.
J Neurosci 23(7):2511-2516, 2003.
2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism.
S. Kishimoto....T. Sugiura.
JBC Papers, in press. (Published on April 23, 2003 as Manuscript M301359200.)
|
April 17, 2003 |
Lisa Walter |
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
M.L. Lopez-Rodriguez....J.A. Ramos.
J Med Chem 46:1512-1522, 2003.
Evidence against the presence of an anandamide transporter.
S.T. Glaser....D. G. Deutsch.
Proc Natl Acad Sci USA 100(7):4269-4274, 2003.
|
April 3, 2003 |
Ken Mackie |
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
P. Derkinderen....J.A. Girault.
J Neurosci 23:2371-2382, 2003.
|
March 20, 2003 |
Christopher Kearn |
The effects of Delta(9)-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.
C.S. Breivogel...B.R. Martin.
Eur J Pharmacol 459:139-150, 2003.
|
March 6, 2003 |
Alex Straiker |
Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus.
J. Kim...B.E. Alger.
J Neurosci 22:10182-10191, 2002.
Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus.
N. Varma...B.E. Alger.
J Neurosci 21:RC188, 2001.
|
February 20, 2003 |
Jane Sullivan |
Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
T. Ohno-Shosaku...M. Kano.
J Neurosci 22:3864-3872, 2002.
|
February 6, 2003 |
Anke Witting |
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
M.L. Casanova...M. Guzman.
J Clin Invest 111:43-50, 2003.
Inhibition of tumor angiogenesis by cannabinoids.
Cristina Blazquez...Manuel Guzman
FASEB J. Jan 2, 2003.
|
January 23, 2003 |
Charles Chavkin |
Structural basis of inward rectification: cytoplasmic pore of the G protein-gated inward rectifier GIRK1 at 1.8 resolution.
M. Nishida & R. MacKinnon.
Cell 111:957-965, 2002.
|
January 9, 2003 |
Nephi Stella |
Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
E. Molina-Holgado...C. Guaza.
J Neurosci 22:9742-9753, 2002.
|
December 12, 2002 |
Eiron Cudaback |
Modulation of anxiety through blockade of anandamide hydrolysis.
S. Kathuria….D. Piomelli.
Nat Med 9(1):76-81, 2003.
|
October 31, 2002 |
Ken Mackie |
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens.
D. Robbe...O.J. Manzoni.
Proc Natl Acad Sci USA (12):8384-8, 2002.
Endocannabinoids facilitate the induction of LTP in the hippocampus.
G. Carlson...B.E. Alter.
Nat Neurosci 5(8):723-4, 2002.
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.
N. Hajos & T.F. Freund.
Neuropharmacology 43(4):503-10, 2002.
|
